Sign In
test

Adam Fliss

Patient Square Capital Lp

Assets Managed
$563.607M
Holdings
29
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
20.66%(2Q avg: 22.81%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Patient Square Capital Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 29 positions.

Assets under management

The assets under management (AUM) of Patient Square Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 563.607M in assets, with a quarterly growth rate of 20.66% and a 2-quarter average growth rate of 22.81%. The portfolio is managed by Adam Fliss, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
ROIV
Roivant Sciences Ltd
Recent Activity
40.14%
$226.2M
8.166M shares@ $27.71 avg price
ARGX
Argenx Se - Adr
Recent Activity
Increased 41.23%
4.76%
$26.813M
36,718 shares@ $730.26 avg price
INSM
Insmed Inc
Recent Activity
Decreased -41.01%
4.57%
$25.754M
157,500 shares@ $163.52 avg price
BGNE
Beigene Ltd-adr
Recent Activity
Increased 16.21%
4.25%
$23.919M
80,542 shares@ $296.98 avg price
COGT
Cogent Biosciences Inc
Recent Activity
Increased 87.8%
4.08%
$22.94M
596,000 shares@ $38.49 avg price
MIRM
Mirum Pharmaceuticals Inc
Recent Activity
Decreased -22.99%
3.77%
$21.247M
230,000 shares@ $92.38 avg price
BLTE
Belite Bio Inc - Adr
Recent Activity
New Position
3.31%
$18.604M
116,684 shares@ $159.45 avg price
LEGN
Legend Biotech Corp-adr
Recent Activity
New Position
3.18%
$17.909M
990,000 shares@ $18.09 avg price
NKTR
Nektar Therapeutics
Recent Activity
New Position
2.69%
$15.11M
210,000 shares@ $71.95 avg price
DBVT
Dbv Technologies Sa-spon Adr
Recent Activity
Increased 93.16%
2.58%
$14.488M
693,534 shares@ $20.89 avg price

1-10 of 29